陈芳有, 李宏焘, 陈杰, 双鹏程, 罗永明. 宽叶金粟兰中1对具有神经保护活性的倍半萜对映体J. 药学学报, 2020,55(8): 1855-1858. doi: 10.16438/j.0513-4870.2020-0491
引用本文: 陈芳有, 李宏焘, 陈杰, 双鹏程, 罗永明. 宽叶金粟兰中1对具有神经保护活性的倍半萜对映体J. 药学学报, 2020,55(8): 1855-1858. doi: 10.16438/j.0513-4870.2020-0491
CHEN Fang-you, LI Hong-tao, CHEN Jie, SHUANG Peng-cheng, LUO Yong-ming. A pair of enantiomeric sesquiterpenoids with neuroprotective effects from Chloranthus henryiJ. Acta Pharmaceutica Sinica, 2020,55(8): 1855-1858. doi: 10.16438/j.0513-4870.2020-0491
Citation: CHEN Fang-you, LI Hong-tao, CHEN Jie, SHUANG Peng-cheng, LUO Yong-ming. A pair of enantiomeric sesquiterpenoids with neuroprotective effects from Chloranthus henryiJ. Acta Pharmaceutica Sinica, 2020,55(8): 1855-1858. doi: 10.16438/j.0513-4870.2020-0491

宽叶金粟兰中1对具有神经保护活性的倍半萜对映体

A pair of enantiomeric sesquiterpenoids with neuroprotective effects from Chloranthus henryi

  • 摘要: 运用硅胶柱色谱、MCI柱色谱、Sephadex LH-20凝胶柱色谱、制备液相色谱等多种色谱技术对金粟兰科植物宽叶金粟兰乙醇提取物进行分离纯化。从中分离得到5个倍半萜类化合物,并应用波谱学方法(MS、IR、NMR)和单晶X射线衍射对分离得到的化合物结构进行了鉴定,分别鉴定为:(1S,6S,8R)-8-ethoxychlomultin C (1a)、(1R,6R,8S)-8-ethoxychlomultin C (1b)、(+)-phaeocaulin D (2)、白术内酯Ⅰ(3)和8-β-ethoxyasterolid (4)。其中化合物1a1b为1对新的倍半萜对映体,化合物24为首次从宽叶金粟兰中分离得到。在10 μmol·L-1浓度下,化合物1a1b23使H2O2损伤的PC12细胞的细胞存活率从(43.41±1.59)%分别提高到(61.71±7.56)%、(66.05±5.61)%、(74.34±3.32)%和(69.58±5.02)%。

     

    Abstract: An ethanol extract of Chloranthus henryi (Chloranthaceae) was subjected to various chromatographic procedures including silica gel column chromatography, MCI column chromatography, Sephadex LH-20 column chromatography, and preparative HPLC. Five purified sesquiterpenes analyzed by spectroscopic analyses (MS, IR, NMR) and single crystal X-ray diffraction were elucidated as (1S,6S,8R)-8-ethoxychlomultin C (1a), (1R,6R,8S)-8-ethoxychlomultin C (1b), (+)-phaeocaulin D (2), atractylenolide Ⅰ (3), and 8-β-ethoxyasterolid (4). Compounds 1a and 1b were a new pair of sesquiterpene enantiomers and compounds 2-4 were isolated from this plant for the first time. Compounds 1a, 1b, 2 and 3 increased cell viability in H2O2-treated PC12 cells from (43.41±1.59)% to (61.71±7.56)%, (66.05±5.61)%, (74.34±3.32)% and (69.58±5.02)% at 10 μmol·L-1, respectively.

     

/

返回文章
返回